Price Alert

Zhengye Biotechnology Hol... (ZYBT)

NASDAQ: ZYBT · Real-Time Price · USD

9.49

1.89 (24.87%)

At close: Aug 20, 2025, 3:59 PM

9.38

-1.16%

After-hours: Aug 20, 2025, 07:59 PM EDT

Zhengye Biotechnology Statistics

Share Statistics

Zhengye Biotechnology has 47.39M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	47.39M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	14,858
FTD / Avg. Volume	4.11%

Short Selling Information

The latest short interest is 246.38K, so 0.52% of the outstanding shares have been sold short.

Short Interest	246.38K
Short % of Shares Out	0.52%
Short % of Float	5.56%
Short Ratio (days to cover)	2.92

Valuation Ratios

PE Ratio	0
Forward PE	n/a
PS Ratio	0
Forward PS	n/a
PB Ratio	0
P/FCF Ratio	0
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Zhengye Biotechnology.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.3.

Current Ratio	1.31
Quick Ratio	0.88
Debt / Equity	0.3
Debt / EBITDA	2.03
Debt / FCF	6.51
Interest Coverage	4.07

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$670.35K
Profits Per Employee	$40.69K
Employee Count	278
Asset Turnover	0.38
Inventory Turnover	1.63

Taxes

Income Tax	924K
Effective Tax Rate	6.42%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0, so Zhengye Biotechnology's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	6.38
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.07
Average Volume (20 Days)	361,601

Income Statement

In the last 12 months, Zhengye Biotechnology had revenue of 186.36M and earned 11.31M in profits. Earnings per share was 0.

Revenue	186.36M
Gross Profit	91.3M
Operating Income	16.44M
Net Income	11.31M
EBITDA	42.6M
EBIT	18.44M
Earnings Per Share (EPS)	0

Full Income Statement

Balance Sheet

The company has 18.6M in cash and 86.43M in debt, giving a net cash position of -67.83M.

Cash & Cash Equivalents	18.6M
Total Debt	86.43M
Net Cash	-67.83M
Retained Earnings	48.15M
Total Assets	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 41.05M and capital expenditures -27.77M, giving a free cash flow of 13.27M.

Operating Cash Flow	41.05M
Capital Expenditures	-27.77M
Free Cash Flow	13.27M
FCF Per Share	0

Full Cash Flow Statement

Margins

Gross margin is 48.99%, with operating and profit margins of 8.82% and 6.07%.

Gross Margin	48.99%
Operating Margin	8.82%
Pretax Margin	7.72%
Profit Margin	6.07%
EBITDA Margin	22.86%
EBIT Margin	8.82%
FCF Margin	7.12%

Dividends & Yields

ZYBT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for ZYBT.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a